B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TAS2R13

MOLECULAR TARGET

taste 2 receptor member 13

UniProt: Q9NYV9NCBI Gene: 508381 compounds

TAS2R13 (taste 2 receptor member 13) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TAS2R13

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on0.691

About TAS2R13 as a Drug Target

TAS2R13 (taste 2 receptor member 13) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented TAS2R13 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TAS2R13 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.